June 12, 2019, 06:02 am

Rubius announces 3 new patents for cellular-therapy program

 12-06-2019 6:02 AM

PROVIDENCE - Rubius Therapeutics, a Cambridge, Mass.-based biotech firm that develops and genetically engineers red blood cells for use in medications for autoimmune disorders, has been issued three new U.S. patents. Two of the issued patents are related to the matter and methods...

Posted in: Tags:
Providence Business News
Providence Business News

This article was posted online by Providence Business News. Spot On Rhode Island collects excepts of news articles from this news source and add these in the 'Rhode Island Business'-category. For mor einformation about Spot On Rhode Island, you can check the About Us-page.

This story was posted in the category: